Manufacture

Pfizer’s latest investment in the UK targets an improvement in pediatric clinical trials.

When it comes to developing cell and gene therapies, you need to keep your eye on the end goal of commercial manufacturing.

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Do you want to share the story behind your technology in a future issue of The Medicine Maker?

Will Gene's Supplier Exchange Program and eData skills get him what he wants?

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

A number of aspects must be considered to design a tablet that is well suited for commercial manufacture.

Biopharma manufacturers have been using the same assays for viral safety testing for decades.

The tablet press is a pharma manufacturing facility staple, but today’s systems need to be faster, more reliable and more flexible than ever before.